MADRAC Bulletin - 03/2019 Edition

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive



MADRAC Bulletin - 03/2019 Edition


Articles based on Case Report 

▪ Erythropoiesis-stimulating agents: A reminder on the cardiovascular risk in patients with chronic kidney disease

▪ Amiodarone: Risk of acute hepatitis

▪ Levothyroxine: Reminder on the risk of restlessness or irritability

▪ Immunisation anxiety-related reactions


What's New?

▪ List of Directives Related to Drug Safety Issues (September - December 2019)




National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email:
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075


The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 21 October 2021, 10:23:41.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA


Main Menu English

Choose Your Language